TruVenturo GmbH — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
CereGateceregate.cominSep 2020
Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders.
AI & Machine LearningDeep TechHealthtechMedical Devices
Matthias Puls(CEO)inBrian Blischak(President)in
Co-investorsCARMA FUNDHeal CapitalHigh Tech Gruenderfonds468 CapitalHTGF
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




